1236964

Genentech, Inc. — FEI 2917293

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 2, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
South San Francisco, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
21360FDCA 505-1(f)(4)Failure to comply with REMS Implementation System